Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Texas-based Spectra Energy Corporation ( SE - Analyst Report ) and Spectra Energy Partners, L.P have inked an agreement with Eastman Chemical Company for a period of 25 years relating to their East Tennessee Natural Gas (ETNG) pipeline.
Per the agreement, the pipeline will supply an incremental 86 million cubic feet per day (MMcf/d) of fixed transportation capacity to Eastman’s Kingsport facility, Tennessee. The transfer of the capacity is planned under two phases.
The total capital costs of the projects are expected to be $120 million. The cost comprises making alterations to the existing ETNG facilities and construction of a new 6.4 mile pipeline extension.
On completion of the projects, ETNG is supposed to supply a fixed capacity of 121 MMcf/d to the Kingsport facility, in addition to the Eastman's current contracts. The first project, which includes supplying 25 MMcf/d of the capacity is anticipated to be commissioned by November 2013.
The Kingsport Expansion Project, which is expected to commence operations in the first quarter of 2015, will provide 61 MMcf/d of additional capacity. The projects are subject to regulatory approvals and consent from the boards of directors of Spectra Energy Corp., Spectra Energy Partners and Eastman Chemical Company.
Spectra Energy through its subsidiaries and equity affiliates, engages in the ownership and operation of a portfolio of complementary natural gas-related energy assets. The company operates in four segments: U.S. Transmission, Distribution, Western Canada Transmission & Processing, and Field Services. Moreover, the company has 50% ownership in DCP Midstream – one of the largest natural gas gatherers and processors in the U.S.
Spectra Energy, which inked an agreement last month to purchase the Express-Platte Pipeline System from Kinder Morgan Energy Partners L.P. ( KMP - Analyst Report ) , holds a Zacks Rank #3 (Short term Hold rating). For the long term, we maintain our Neutral recommendation.
Read the full Analyst Report on KMP
Read the full Analyst Report on SE